DNA Elements Underlying Celiac and Crohn's Susceptibility

乳糜泻和克罗恩病易感性的 DNA 元素

基本信息

  • 批准号:
    9664318
  • 负责人:
  • 金额:
    $ 16.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-09 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Well powered genome-wide association studies (GWAS) for celiac disease and Crohn's disease have identified numerous non-HLA susceptibility loci. Genetic fine-mapping and expression quantitative trait loci (eQTL) can narrow in on which genes probably account for the GWAS signals, but even after these approaches the locations of the causal nucleotide changes often remain unknown. This gap in understanding is a roadblock to targeted prevention and therapy. As developed in our prior work, mapping haplotype-dependent allele-specific CpG methylation (hap-ASM) and methylation quantitative trait loci (mQTLs) in cells relevant to a given disease, and then overlapping these epigenetic maps with GWAS data, can help to hone in on the DNA regulatory sequences that causally underlie the GWAS signals. Our hypothesis is that this combined genetic-epigenetic mapping strategy, followed by functional assays, will be able to identify regulatory DNA sequences that contribute to celiac disease and Crohn's disease susceptibility and pathogenesis. First, we will carry out Methyl-Seq of CD4+ and CD8+ T cells and peripheral blood monocytes, to map hap-ASM genome-wide. These data will pinpoint hap- ASM differentially methylated regions (DMRs) in the same haplotype blocks as GWAS peaks for celiac and Crohn's. Since hap-ASM often reflects allele-specific transcription factor binding site (TFBS) or insulator occupancies, we will cross-validate our findings using an independent method, Assay for Transposase- Accessible Chromatin Sequencing (ATAC-Seq). In our second aim, we will rank and prioritize the hap-ASM DMRs based on the strength of the allelic asymmetries, ATAC-Seq overlaps, and linkage disequilibrium (LD) with GWAS peak SNPs, and perform high-throughput targeted bisulfite sequencing to fine-map the top-ranked DMRs, both in the blood-derived cells and in mucosal T cells from celiac and Crohn's patients. In our third aim, to definitively test the functional roles of specific TFBS in the DMRs, we will use CRISPR to delete these sequences in Jurkat cells and in normal T cells. We will score effects of the deletions on local methylation patterns and mRNA levels of each of the nearby genes. These data will clarify our fundamental understanding of susceptibility and pathogenesis of celiac disease and Crohn's disease.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin Tycko其他文献

Benjamin Tycko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin Tycko', 18)}}的其他基金

Identifying and characterizing functional noncoding mutations in multiple myeloma
识别和表征多发性骨髓瘤的功能性非编码突变
  • 批准号:
    10586759
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Genetic-epigenetic and aging interactions at COVID- 19 host response loci in Down syndrome and mouse models
唐氏综合症和小鼠模型中 COVID-19 宿主反应位点的遗传-表观遗传和衰老相互作用
  • 批准号:
    10221384
  • 财政年份:
    2017
  • 资助金额:
    $ 16.84万
  • 项目类别:
Epigenetics of Down Syndrome
唐氏综合症的表观遗传学
  • 批准号:
    9977004
  • 财政年份:
    2017
  • 资助金额:
    $ 16.84万
  • 项目类别:
Epigenetics of Down Syndrome
唐氏综合症的表观遗传学
  • 批准号:
    9898045
  • 财政年份:
    2017
  • 资助金额:
    $ 16.84万
  • 项目类别:
Epigenetics of Down Syndrome
唐氏综合症的表观遗传学
  • 批准号:
    10200867
  • 财政年份:
    2017
  • 资助金额:
    $ 16.84万
  • 项目类别:
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
通过 DNA 低甲基化靶向癌症相关肌成纤维细胞
  • 批准号:
    8555378
  • 财政年份:
    2011
  • 资助金额:
    $ 16.84万
  • 项目类别:
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
通过 DNA 低甲基化靶向癌症相关肌成纤维细胞
  • 批准号:
    8256911
  • 财政年份:
    2011
  • 资助金额:
    $ 16.84万
  • 项目类别:
Epigenetic Modifiers in Down Syndrome
唐氏综合症的表观遗传修饰剂
  • 批准号:
    7976426
  • 财政年份:
    2010
  • 资助金额:
    $ 16.84万
  • 项目类别:
Optimizing MSNP for profiling DNA methylation in cancers and precursor lesions
优化 MSNP 以分析癌症和癌前病变中的 DNA 甲基化
  • 批准号:
    7902107
  • 财政年份:
    2009
  • 资助金额:
    $ 16.84万
  • 项目类别:
Optimizing MSNP for profiling DNA methylation in cancers and precursor lesions
优化 MSNP 以分析癌症和癌前病变中的 DNA 甲基化
  • 批准号:
    7660795
  • 财政年份:
    2009
  • 资助金额:
    $ 16.84万
  • 项目类别:

相似国自然基金

煤矸石风化颗粒的潜在致霾作用研究
  • 批准号:
    41902172
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
海洋酸化对潜在有害痕量元素在沉积物—海水界面迁移扩散及循环转化的影响研究
  • 批准号:
    41806133
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
免耕秸秆覆盖下黑土磷素形态转化的微生物调控机制及潜在环境效应
  • 批准号:
    41807108
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
丹江口库区退耕还林下微生物周转土壤有机磷特征及潜在的环境效应
  • 批准号:
    31700461
  • 批准年份:
    2017
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
燃煤电厂排放的潜在有毒痕量元素对环境的影响
  • 批准号:
    49372159
  • 批准年份:
    1993
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目

相似海外基金

Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
多效性乳腺癌、前列腺癌和卵巢癌风险位点的共同生物学基础
  • 批准号:
    10366397
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
多效性乳腺癌、前列腺癌和卵巢癌风险位点的共同生物学基础
  • 批准号:
    10684639
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
Veri-T:Verdiperstat 治疗由潜在 FTLD-TDP 引起的语义变异原发性进行性失语症的 1 期安慰剂对照试验
  • 批准号:
    10459524
  • 财政年份:
    2021
  • 资助金额:
    $ 16.84万
  • 项目类别:
Genetic and neural mechanisms underlying emerging social behavior in zebrafish
斑马鱼新兴社会行为的遗传和神经机制
  • 批准号:
    10306905
  • 财政年份:
    2021
  • 资助金额:
    $ 16.84万
  • 项目类别:
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
Veri-T:Verdiperstat 治疗由潜在 FTLD-TDP 引起的语义变异原发性进行性失语症的 1 期安慰剂对照试验
  • 批准号:
    10280622
  • 财政年份:
    2021
  • 资助金额:
    $ 16.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了